Delivery Order SPE2DB22D1103-SPE2DB25FTFT0
Award Date
2/18/25
Potential Completion Date
2/19/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNK92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $1,861.79 and a completion date of November 6, 2024. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This federal contract award, valued at $8,025.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a completion date of February 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, with an ID of SPE2DB20D2014|SPE2DB25FB15B, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% cream, a pharmaceutical product, with a ceiling value of $21,036.72 and a completion date of February 24, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a ceiling value of $12,900.63 and an ultimate completion date of December 3, 2024. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is not designated as a set-aside....
This federal contract award, with ID SPE2DB20D3505|SPE2DB24FU6F6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $6,156.46, is for the provision of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of July 16, 2024. It is not designated as a set-aside contract....
This federal contract award, with an ID of SPE2DB22D1017|SPE2DB25FE8YR, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $3,214.71 and a completion date of November 13, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $6,179.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDMZ7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,151.70 fixed-price delivery order contract is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN46A, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order valued at $21,104.43, is for the supply of OPZELURA 1.5% CREAM 60GM, a medical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 31, 2025. Amerisourcebergen Drug Corp is the prime contractor...
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FH7AJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,778.96 firm fixed-price delivery order is for the pharmaceutical product OPZELURA 1.5% Cream, 60GM. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal...